Quest Diagnostics Incorporated (DGX)

Name: Quest Diagnostics Incorporated (DGX) — histórico de demonstrações financeiras
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Histórico de receita, lucros e fluxo de caixa das demonstrações financeiras oficiais.

Health Care · Wall Street (EUA) · Última atualização: 2026-09-18

A Quest Diagnostics Incorporated fornece testes e serviços de diagnóstico nos Estados Unidos. A empresa desenvolve e fornece serviços de informações diagnósticas, como testes clínicos de rotina, não rotineiros e avançados, testes de anatomia patológica e outros serviços de informações diagnósticas.

Traduzido automaticamente

Números-chave

Capitalização de mercado: $27 billion
Receita (exercício encerrado em 2025-12-31): $11.0B
Lucro líquido: $992M
Margem bruta: 31.9%
Margem líquida: 9.0%

Ver gráficos interativos e demonstrações completas → Modelo de avaliação (DCF) →

Demonstração de resultados anual

Demonstração de resultados	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Receita total	$11.6B	$11.0B	$9.9B	$9.3B	$9.9B	$10.8B	$9.4B	$7.7B	$7.5B	$7.7B	$7.5B	$7.5B	$7.4B	$7.1B	$7.4B	$7.5B	$7.4B	$7.5B	$7.2B	$6.7B	$6.3B
Lucro bruto	$3.8B	$3.5B	$3.2B	$3.1B	$3.4B	$4.2B	$3.6B	$2.7B	$2.6B	$3.0B	$2.9B	$2.8B	$2.8B	$2.8B	$3.0B	$3.1B	$3.1B	$3.1B	$3.0B	$2.7B	$2.6B
Margem Bruta %	33.1%	31.9%	32.9%	33.0%	34.7%	39.0%	38.5%	34.8%	34.6%	38.8%	38.6%	37.9%	37.6%	39.5%	40.9%	41.5%	41.4%	42.0%	41.3%	40.8%	41.0%
Resultado Operacional (EBIT)	$1.6B	$1.6B	$1.3B	$1.3B	$1.4B	$2.4B	$2.0B	$1.2B	$1.1B	$1.2B	$1.3B	$1.4B	$983M	$1.5B	$1.2B	$995M	$1.3B	$1.4B	$1.2B	$1.1B	$1.1B
% de margem operacional	14.1%	14.5%	13.6%	13.6%	14.4%	22.1%	20.9%	15.9%	14.6%	15.1%	17.0%	18.7%	13.2%	20.6%	16.3%	13.2%	17.6%	18.2%	16.9%	16.3%	18.0%
Resultado líquido	$1.1B	$992M	$871M	$854M	$946M	$2.0B	$1.4B	$858M	$736M	$772M	$645M	$709M	$556M	$849M	$556M	$471M	$721M	$729M	$582M	$340M	$586M
Margem Líquida %	9.2%	9.0%	8.8%	9.2%	9.6%	18.5%	15.2%	11.1%	9.8%	10.0%	8.6%	9.5%	7.5%	11.9%	7.5%	6.3%	9.8%	9.8%	8.0%	5.1%	9.3%
EBITDA	$2.0B	$2.2B	$1.9B	$1.3B	$1.8B	$3.2B	$2.4B	$1.6B	$1.4B	$1.5B	$1.5B	$1.6B	$1.3B	$1.8B	$1.5B	$1.3B	$1.6B	$1.6B	$1.5B	$1.3B	$1.3B
Lucro por ação (EPS)	$9.46	$8.78	$7.71	$7.56	$8.02	$15.59	$10.52	$6.31	$5.29	$5.51	$4.54	$4.89	$3.83	$5.55	$3.47	$2.94	$4.07	$3.88	$2.97	$1.74	$2.94
Ações em circulação (M)	112M	113M	113M	113M	118M	128M	136M	136M	139M	140M	142M	145M	145M	153M	160M	160M	177M	188M	196M	195M	200M

Fonte: relatórios públicos da empresa (SEC). Verifique no SEC EDGAR antes de confiar em qualquer número.

Balanços, fluxos de caixa, dados trimestrais e indicadores completos no visualizador interativo de DGX. /companies/us/DGX

Empresas semelhantes

As informações deste site são apenas educacionais e informativas; não constituem recomendação de investimento. Não publicamos preços-alvo nem recomendações.

English version →Todas as ações

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.